129 related articles for article (PubMed ID: 11948841)
1. Pelvic lymph node visualization with MR imaging using local administration of ultra-small superparamagnetic iron oxide contrast.
McCauley TR; Rifkin MD; Ledet CA
J Magn Reson Imaging; 2002 Apr; 15(4):492-7. PubMed ID: 11948841
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance lymphography in rats: effects of muscular activity and hyperthermia on the lymph node uptake of intravenously injected superparamagnetic iron oxide particles.
Elste V; Wagner S; Taupitz M; Pfefferer D; Kresse M; Hamm B; Berg R; Wolf KJ; Semmler W
Acad Radiol; 1996 Aug; 3(8):660-6. PubMed ID: 8796730
[TBL] [Abstract][Full Text] [Related]
3. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
4. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging.
Dinniwell R; Chan P; Czarnota G; Haider MA; Jhaveri K; Jewett M; Fyles A; Jaffray D; Milosevic M
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):844-51. PubMed ID: 19095369
[TBL] [Abstract][Full Text] [Related]
5. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck.
Anzai Y; McLachlan S; Morris M; Saxton R; Lufkin RB
AJNR Am J Neuroradiol; 1994 Jan; 15(1):87-94. PubMed ID: 7511324
[TBL] [Abstract][Full Text] [Related]
6. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
Tatsumi Y; Tanigawa N; Nishimura H; Nomura E; Mabuchi H; Matsuki M; Narabayashi I
Gastric Cancer; 2006; 9(2):120-8. PubMed ID: 16767368
[TBL] [Abstract][Full Text] [Related]
7. Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study.
Hudgins PA; Anzai Y; Morris MR; Lucas MA
AJNR Am J Neuroradiol; 2002 Apr; 23(4):649-56. PubMed ID: 11950660
[TBL] [Abstract][Full Text] [Related]
8. [Sentinel lymph node after intramammary injection of superparamagnetic iron oxide].
Ishiyama K; Sashi R; Katayose Y; Tomura N; Watarai J; Narita K
Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Nov; 62(13):744-6. PubMed ID: 12508494
[TBL] [Abstract][Full Text] [Related]
9. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
Deserno WM; Harisinghani MG; Taupitz M; Jager GJ; Witjes JA; Mulders PF; Hulsbergen van de Kaa CA; Kaufmann D; Barentsz JO
Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228
[TBL] [Abstract][Full Text] [Related]
10. Visualization of superior mesenteric lymph nodes by the combined oral and intravenous administration of the ultrasmall superparamagnetic iron oxide, AMI-227.
Rogers JM; Lewis J; Josephson L
Magn Reson Imaging; 1994; 12(8):1161-5. PubMed ID: 7854022
[TBL] [Abstract][Full Text] [Related]
11. A verification study of proposed pelvic lymph node localisation guidelines using nanoparticle-enhanced magnetic resonance imaging.
Vilarino-Varela MJ; Taylor A; Rockall AG; Reznek RH; Powell ME
Radiother Oncol; 2008 Nov; 89(2):192-6. PubMed ID: 18771811
[TBL] [Abstract][Full Text] [Related]
12. Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON).
Korosoglou G; Tang L; Kedziorek D; Cosby K; Gilson WD; Vonken EJ; Schär M; Sosnovik D; Kraitchman DL; Weiss RG; Weissleder R; Stuber M
J Magn Reson Imaging; 2008 May; 27(5):1175-80. PubMed ID: 18425827
[TBL] [Abstract][Full Text] [Related]
13. MR lymphography using iron oxide nanoparticles in rats: pharmacokinetics in the lymphatic system after intravenous injection.
Réty F; Clément O; Siauve N; Cuénod CA; Carnot F; Sich M; Buisine A; Frija G
J Magn Reson Imaging; 2000 Nov; 12(5):734-9. PubMed ID: 11050643
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration.
Bengele HH; Palmacci S; Rogers J; Jung CW; Crenshaw J; Josephson L
Magn Reson Imaging; 1994; 12(3):433-42. PubMed ID: 8007773
[TBL] [Abstract][Full Text] [Related]
15. Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma.
Nguyen BC; Stanford W; Thompson BH; Rossi NP; Kernstine KH; Kern JA; Robinson RA; Amorosa JK; Mammone JF; Outwater EK
J Magn Reson Imaging; 1999 Sep; 10(3):468-73. PubMed ID: 10508310
[TBL] [Abstract][Full Text] [Related]
16. MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent.
Pannu HK; Wang KP; Borman TL; Bluemke DA
J Magn Reson Imaging; 2000 Dec; 12(6):899-904. PubMed ID: 11105028
[TBL] [Abstract][Full Text] [Related]
17. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?
Harisinghani MG; Saksena MA; Hahn PF; King B; Kim J; Torabi MT; Weissleder R
AJR Am J Roentgenol; 2006 Jan; 186(1):144-8. PubMed ID: 16357394
[TBL] [Abstract][Full Text] [Related]
18. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.
Harisinghani MG; Saini S; Weissleder R; Hahn PF; Yantiss RK; Tempany C; Wood BJ; Mueller PR
AJR Am J Roentgenol; 1999 May; 172(5):1347-51. PubMed ID: 10227514
[TBL] [Abstract][Full Text] [Related]
19. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide.
Nishimura H; Tanigawa N; Hiramatsu M; Tatsumi Y; Matsuki M; Narabayashi I
J Am Coll Surg; 2006 Apr; 202(4):604-11. PubMed ID: 16571430
[TBL] [Abstract][Full Text] [Related]
20. Distribution of iron oxide nanoparticles in rat lymph nodes studied using electron energy loss spectroscopy (EELS) and electron spectroscopic imaging (ESI).
Bordat C; Sich M; Réty F; Bouet O; Cournot G; Cuénod CA; Clément O
J Magn Reson Imaging; 2000 Sep; 12(3):505-9. PubMed ID: 10992320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
